Hm Payson & CO Bio Rad Laboratories, Inc. Transaction History
Hm Payson & CO
- $5.81 Billion
- Q3 2024
A detailed history of Hm Payson & CO transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Hm Payson & CO holds 50 shares of BIO stock, worth $17,087. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$17,087
Previous $13,000
23.08%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
458Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$652 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$530 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$446 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$371 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$244 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.42B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...